Rimteravimab
Based on 1 Customer Validation
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2.
For research use only. We do not sell to patients.
- Purity: ≥99%
- CAS No.: 2540797-21-3
- Molecular Weight:79.1 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
[G1 VH-h-CH2-CH3] - dimer
Virus
SARS-CoV-2 S protein
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:K18-hACE2 transgenic mouse model[2]
-
Dosage:4-20 mg/kg
-
Administration:ip, single dose
-
Result:Reduced the infectious virus and viral genomic RNA in lungs.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
[G1 VH-h-CH2-CH3]-dimer
ELISA, FACS, Functional assay
-
Loaded Rimteravimab on AHC2 biosensor, can bind SARS-CoV-2 S Protein RBD (sf9, His, HY-P73664) with an affinity constant of 8.111E-09 M as determined in BLI assay.
Chemical Information
-
CAS No. 2540797-21-3
-
Appearance Liquid
-
Molecular Weight 79.1 kDa
-
Color Colorless to light yellow
-
SMILES
[Rimteravimab]
-
Synonyms
XVR011
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Bert Schepens, et al. An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models. Sci Transl Med. 2021 Nov 24;13(621):eabi7826. [Content Brief]
[2]. Schepens B, et al., An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models. Sci Transl Med. 2021 Nov 24;13(621):eabi7826. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)